web analytics

Actiste – world’s first unified IoT diabetes care device – has received market approval (CE mark).

Actiste®, the world’s first unified diabetes care device with eSIM technology for monitoring and treating insulin-dependent diabetes, has received not only one, but two, EC certificates (CE marks) from TÜV Rheinland (Notified Body).

“This is a truly unique situation in a European regulatory context,” says Brighter’s CEO Henrik Norström.

The EC certifications allows the company to move forward with its ongoing market entry and sales activities in the company’s primary target markets in the Middle East and Southeast Asia, and opens up for future sales in over 30 European countries,

Source: Actiste – world’s first unified IoT diabetes care device – has received market approval (CE mark).

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.